Zusammenfassung
Der neuropathische Schmerz ist ein Schmerz, der durch eine Läsion oder Erkrankung des somatosensorischen Nervensystems verursacht wird. Wissenschaftliche Untersuchungen konnten belegen, dass neuropathische Schmerzen Folge komplex veränderter Signalprozesse im peripheren und im Zentralnervensystem sind. Aktuelle Therapien neuropathischer Schmerzen sind kausal orientiert, haben aber auch symptomatisch die Analgesie durch pharmakologische und nichtpharmakologische Methoden zum Ziel. Weiterhin werden psychologische Schmerzbewältigungstechniken supportiv eingesetzt. Diese Übersicht fasst die zeitgemäße Diagnostik neuropathischer Schmerzen am Beispiel häufiger Erkrankungen zusammen und stellt die Evidenz aus randomisierten kontrollierten Studien zur Therapie neuropathischer Schmerzen vor. Die Behandlungsrichtlinien zur pharmakologischen Beeinflussung neuropathischer Schmerzen umfassen den evidenzbasierten Einsatz von Antidepressiva, Antikonvulsiva, Opioiden, Capsaicin und Lidocain.
Abstract
Neuropathic pain is pain caused by a lesion or disease of the somatosensory nervous system. Scientific studies have shown that neuropathic pain is the result of complex altered signalling processes in the peripheral and central nervous system. Current forms of treatment of neuropathic pain are causally oriented but also aim at symptomatic analgesia by pharmacological and nonpharmacological methods. Furthermore, psychological pain management techniques are used in a supportive role. This review summarizes the contemporary diagnostics of neuropathic pain using frequent diseases as examples and presents the evidence from randomized controlled trials on the treatment of neuropathic pain. Treatment guidelines for pharmacological management of neuropathic pain include evidence-based use of antidepressants, anticonvulsants, opioids, capsaicin and lidocaine.
Literatur
Attal N, Bouhassira D, Baron R (2018) Diagnosis and assessment of neuropathic pain through questionnaires. Lancet Neurol 17:456–466
Attal N, Cruccu G, Baron R et al (2010) EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 17:e1113–e1188
Attal N, De Andrade DC, Adam F et al (2016) Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial. Lancet Neurol 15:555–565
Baron R, Maier C, Attal N et al (2017) Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles. Pain 158:261–272
Beloeil H, Sion B, Rousseau C et al (2017) Early postoperative neuropathic pain assessed by the DN4 score predicts an increased risk of persistent postsurgical neuropathic pain. Eur J Anaesthesiol 34:652–657
Bendtsen L, Zakrzewska JM, Heinskou TB et al (2020) Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia. Lancet Neurol 19:784–796
Bennett M (2001) The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain 92:147–157
Bhaskar A, Bell A, Boivin M et al (2021) Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process. J Cannabis Res 3:22
Bouhassira D, Attal N, Alchaar H et al (2005) Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114:29–36
Bouhassira D, Lanteri-Minet M, Attal N et al (2008) Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136:380–387
Broggi G, Ferroli P, Franzini A et al (2000) Microvascular decompression for trigeminal neuralgia: comments on a series of 250 cases, including 10 patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 68:59–64
Casser HR, Huppe M, Kohlmann T et al (2012) German pain questionnaire and standardised documentation with the KEDOQ-Schmerz. A way for quality management in pain therapy. Schmerz 26:168–175
Chaparro LE, Smith SA, Moore RA et al (2013) Pharmacotherapy for the prevention of chronic pain after surgery in adults. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD008307.pub2
Chen Q, Chen E, Qian X (2021) A narrative review on perioperative pain management strategies in enhanced recovery pathways-the past, present and future. J Clin Med 10(12):2568. https://doi.org/10.3390/jcm10122568
Chen YK, Boden KA, Schreiber KL (2021) The role of regional anaesthesia and multimodal analgesia in the prevention of chronic postoperative pain: a narrative review. Anaesthesia 76(Suppl 1):8–17
Cruccu G, Truini A (2017) A review of neuropathic pain: from guidelines to clinical practice. Pain Ther 6:35–42
De Greef BTA, Hoeijmakers JGJ, Geerts M et al (2019) Lacosamide in patients with Nav1.7 mutations-related small fibre neuropathy: a randomized controlled trial. Brain 142:263–275
Demant DT, Lund K, Vollert J et al (2014) The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study. Pain 155:2263–2273
Derry S, Rice AS, Cole P et al (2017) Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD007393.pub3
Dieleman JP, Kerklaan J, Huygen F et al (2008) Incidence rates and treatment of neuropathic pain conditions in the general population. Pain 137:681–688
Dillmann U, Nilges P, Saile H et al (1994) Assessing disability in chronic pain patients. Schmerz 8:100–110
Farrar JT, Young JP Jr, Lamoreaux L et al (2001) Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94:149–158
Finnerup NB, Attal N, Haroutounian S et al (2015) Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 14:162–173
Finnerup NB, Haroutounian S, Kamerman P et al (2016) Neuropathic pain: an updated grading system for research and clinical practice. Pain 157:1599–1606
Fitzcharles MA, Cohen SP, Clauw DJ et al (2021) Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet 397:2098–2110
Forbes HJ, Thomas SL, Smeeth L et al (2016) A systematic review and meta-analysis of risk factors for postherpetic neuralgia. Pain 157:30–54
Freynhagen R, Baron R, Gockel U et al (2006) painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 22:1911–1920
Freynhagen R, Parada HA, Calderon-Ospina CA et al (2019) Current understanding of the mixed pain concept: a brief narrative review. Curr Med Res Opin 35:1011–1018
Gilron I, Tu D, Holden RR et al (2015) Combination of morphine with nortriptyline for neuropathic pain. Pain 156:1440–1448
Haanpaa M, Attal N, Backonja M et al (2011) NeuPSIG guidelines on neuropathic pain assessment. Pain 152:14–27
Hauser W, Bock F, Huppe M et al (2020) Recommendations of the second update of the LONTS guidelines : Long-term opioid therapy for chronic noncancer pain. Schmerz 34:204–244
Holbech JV, Bach FW, Finnerup NB et al (2015) Imipramine and pregabalin combination for painful polyneuropathy: a randomized controlled trial. Pain 156:958–966
Ihs (2018) Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38:1–211
Jensen MP, Karoly P, Braver S (1986) The measurement of clinical pain intensity: a comparison of six methods. Pain 27:117–126
Kehlet H, Jensen TS, Woolf CJ (2006) Persistent postsurgical pain: risk factors and prevention. Lancet 367:1618–1625
Knorr JP, Barlow A, Reinaker TS et al (2021) A single dose of pre-operative pregabalin reduces post-operative opioid use after orthotopic liver transplantation. Clin Transplant 35(7):e14319. https://doi.org/10.1111/ctr.14319
Kuiken TA, Schechtman L, Harden RN (2005) Phantom limb pain treatment with mirtazapine: a case series. Pain Pract 5:356–360
Labau JIR, Estacion M, Tanaka BS et al (2020) Differential effect of lacosamide on Nav1.7 variants from responsive and non-responsive patients with small fibre neuropathy. Brain 143:771–782
Lutz J, Thon N, Stahl R et al (2016) Microstructural alterations in trigeminal neuralgia determined by diffusion tensor imaging are independent of symptom duration, severity, and type of neurovascular conflict. J Neurosurg 124:823–830
Maarbjerg S, Benoliel R (2021) The changing face of trigeminal neuralgia—A narrative review. Headache 61:817–837
Moisset X, Bouhassira D, Avez Couturier J et al (2020) Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations. Rev Neurol 176:325–352
Moulin D, Boulanger A, Clark AJ et al (2014) Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society. Pain Res Manag 19:328–335
Mu A, Weinberg E, Moulin DE et al (2017) Pharmacologic management of chronic neuropathic pain: Review of the Canadian Pain Society consensus statement. Can Fam Physician 63:844–852
Mucke M, Phillips T, Radbruch L et al (2018) Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.cd012182.pub2
Nilges P, Essau C (2015) Depression, anxiety and stress scales: DASS—A screening procedure not only for pain patients. Schmerz 29:649–657
Nishihara M, Arai YCP, Yamamoto Y et al (2013) Combinations of low-dose antidepressants and low-dose pregabalin as useful adjuvants to opioids for intractable, painful bone metastases. Pain Phys 16:E547–E552
Ostgathe C, Voltz R, Van Aaaken A et al (2012) Practicability, safety, and efficacy of a „German model“ for opioid conversion to oral levo-methadone. Support Care Cancer 20:2105–2110
Petzke F, Hüppe M, Kohlmann T, Kükens-Höner S, Lindena G, Pfingsten M, Nagel N (2020) Handbuch Deutscher Schmerz-Fragebogen. https://www.schmerzgesellschaft.de/fileadmin/user_upload/DSF-Handbuch_2020.pdf. Zugegriffen: 07.05.2021
Petzke F, Karst M, Gastmeier K et al (2019) Position paper on medical cannabis and cannabis-based medicines in pain medicine. Schmerz 33:449–465
Pickering G, Lucchini C (2020) Topical treatment of localized neuropathic pain in the elderly. Drugs Aging 37:83–89
Pogatzki-Zahn E (2021) Prediction and prevention of chronic postoperative pain. Schmerz 35:30–43
Robertson K, Marshman LAG, Plummer D et al (2019) Effect of gabapentin vs pregabalin on pain intensity in adults with chronic sciatica: a randomized clinical trial. JAMA Neurol 76:28–34
Rolke R, Baron R, Maier C et al (2006) Quantitative sensory testing in the German research network on neuropathic pain (DFNS): standardized protocol and reference values. Pain 123:231–243
Schlereth T (2020) Guideline „diagnosis and non interventional therapy of neuropathic pain“ of the German Society of Neurology (deutsche Gesellschaft fur Neurologie). Neurol Res Pract 2:16
Tait RC, Chibnall JT, Krause S (1990) The pain disability index: psychometric properties. Pain 40:171–182
Tomasello F, Esposito F, Abbritti RV, Angileri FF, Conti A, Cardali SM, La Torre D (2016) Microvascular decompression for trigeminal neuralgia: technical refinement for complication avoidance. World Neurosurg 94:26–31
Van Seventer R, Vos C, Meerding W et al (2010) Linguistic validation of the DN4 for use in international studies. Eur J Pain 14:58–63
Vollert J, Magerl W, Baron R et al (2018) Pathophysiological mechanisms of neuropathic pain: comparison of sensory phenotypes in patients and human surrogate pain models. Pain 159:1090–1102
Weinstein EJ, Levene JL, Cohen MS et al (2018) Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent postoperative pain in adults and children. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD007105.pub3
Ziegler D (2008) Painful diabetic neuropathy: treatment and future aspects. Diabetes Metab Res Rev 24(Suppl 1):S52–S57
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
G. Gossrau und R. Sabatowski geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Gossrau, G., Sabatowski, R. Diagnostik und Therapie neuropathischer Schmerzen. Anaesthesist 70, 993–1002 (2021). https://doi.org/10.1007/s00101-021-01039-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00101-021-01039-x